Tailored HIV-1 vectors for genetic modification of primary human dendritic cells and monocytes.
Monocyte-derived dendritic cells (MDDCs) play a key role in the regulation of the immune system and are the target of numerous gene therapy applications. The genetic modification of MDDCs is possible with human immunodeficiency virus type 1 (HIV-1)-derived lentiviral vectors (LVs) but requires high viral doses to bypass their natural resistance to viral infection, and this in turn affects their physiological properties. To date, a single viral protein is able to counter this restrictive phenotype, Vpx, a protein derived from members of the HIV-2/simian immunodeficiency virus SM lineage that counters at least two restriction factors present in myeloid cells. By tagging Vpx with a short heterologous membrane-targeting domain, we have obtained HIV-1 LVs incorporating high levels of this protein (HIV-1-Src-Vpx). These vectors efficiently transduce differentiated MDDCs and monocytes either as previously purified populations or as populations within unsorted peripheral blood mononuclear cells (PBMCs). In addition, these vectors can be efficiently pseudotyped with receptor-specific envelopes, further restricting their cellular tropism almost uniquely to MDDCs. Compared to conventional HIV-1 LVs, these novel vectors allow for an efficient genetic modification of MDDCs and, more importantly, do not cause their maturation or affect their survival, which are unwanted side effects of the transduction process. This study describes HIV-1-Src-Vpx LVs as a novel potent tool for the genetic modification of differentiated MDDCs and of circulating monocyte precursors with strong potential for a wide range of gene therapy applications.
Department of Human Virology, ENS-L, Lyon, France.
Stéphanie
S
Durand
Xuan-Nhi
XN
Nguyen
Jocelyn
J
Turpin
Stephanie
S
Cordeil
Nicolas
N
Nazaret
Séverine
S
Croze
Renaud
R
Mahieux
Joël
J
Lachuer
Catherine
C
Legras-Lachuer
Andrea
A
Cimarelli
D002478:Cells, Cultured; D003713:Dendritic Cells / Q000821:virology*; D005822:Genetic Vectors; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D015498:HIV-2 / Q000235:genetics; D006801:Humans; D009000:Monocytes / Q000821:virology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics; D014161:Transduction, Genetic; D054334:Viral Regulatory and Accessory Proteins / Q000235:genetics / Q000378:metabolism*
D054334:Viral Regulatory and Accessory Proteins